Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE)

ASGE Technology Committee; Copland AP, Sakaria SS, Abdi M, Akshintala VS, Bhatt A, Bucobo JC, Chen D, Chen YI, Das KK, Desilets DJ, Girotra M,[...]

Zhang D, Leitman M, Pawar S, Shera S, Hernandez L, Jacobs JP, Dong TS. The Association Between Prevotella copri and Advanced Fibrosis in the Progression of Metabolic[...]

Koric A, Chang CE, Lee YA, Wei M, Lee C, Wang J, Hashibe M. Incident depression after breast cancer among older Asian, Native Hawaiian, and[...]